Montreal, Que. (February 1st 2007)
SOLABS — a practice-based company providing solutions for good manufacturing practices, workflow and records management for life-science companies, has joined SAFE BioPharma Association as a Vendor-Partner. The Montreal-based company will be adapting its software to enable utilization of the SAFE™ digital signature standard, which provides a secure, enforcea- ble and regulatory compliant way to verify the identity of parties in business-to-business and business-to- regulator electronic transactions.
"We are delighted to welcome Solabs to the SAFE Vendor Partner Program and its commitment to employ the SAFE digital standard in streamlining good manufacturing practices within life sciences environments", said Mollie Shields-Uehling, President and CEO, SAFE BioPharma Association.
"Our association with SAFE-BioPharma enhances SOLABS global position as an effective resource for pharmaceutical companies to better manage high security documents associated with good manufacturing practices and for improved work flow and records management", said Richard Fecteau, President and CEO, SOLABS
About SOLABS
SOLABS is a practice-based solution company for GxP documents, workflow and records management. It operates a "Software as a Service" (SaaS) business model providing knowledge, best practice, consulting and IT solutions dedicated to the GxP regulated life sciences environment at all points along the drug development lifecycle. SOLABS provides web-based software and is able to provide global support throug its network of partners, collaborators and distributors. SOLABS helps clients to recognize GxP regulatory compliance as a strategic advantage. SOLABS GxP solutions bring tangible benefits through quickly implementing corporate solutions and cementing process workflow learnings across organizations. This is complemented by full-automated traceability, real-time visibility and reduction in errors and lost documents. For more information visit www.solabs.com.
About SAFE-BioPharma
Association SAFE-BioPharma Association is the non-profit asso- ciation that created and manages the SAFE™ digital identity and signature standard for the pharmaceutical and healthcare industries. Through the SAFE standard, the association promotes interoperability and integra- tion among researchers, vendors, regulators, clinicians and other pharmaceutical and healthcare stakeholders. The SAFE standard provides a secure, enforceable, and regulatory compliant way to verify the identities of parties involved in business-to-business and business- to-regulator electronic transactions. SAFE stands for "Signatures and Authentication For Everyone." The Association's founder-members include AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & John- son, Merck, Pfizer, Procter & Gamble, and Sanofi-Aventis. For more information visit www.safe-biopharma.org.
SAFE™ is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.
SOLABS
Ericka Moore — Marketing
514 287-1368 ext: 219
cell: 514 942-2770
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.solabs.com |
